/Investor DB

ALTITUDE LIFE SCIENCE VENTURES — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Generate Biomedicinesgeneratebiomedicines.comin𝕏NASDAQ: GENBNov 2021 · $370M

Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.

AI & Machine LearningBiotechDeep TechSomerville, US

Gevorg Grigoryan(Founder)inMichael Nally(Chief Executive Officer)inAvak Kahvejian(Founder)Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)

Co-investorsFlagship PioneeringAlumni VenturesARCH Venture PartnersMarch Capital PartnersNVIDIAAlaska Permanent Fund Corporation+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.